Randomized placebo-controlled study of the efficacy of botulinum toxin type A (Botox) in spontaneous pain and allodynia related to traumatic nerve injury or postherpetic neuralgia

Trial Profile

Randomized placebo-controlled study of the efficacy of botulinum toxin type A (Botox) in spontaneous pain and allodynia related to traumatic nerve injury or postherpetic neuralgia

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Nov 2008

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Neuropathic pain; Postherpetic neuralgia
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Nov 2008 Results have been published in Annals of Neurology 64: 274-284, No. 3, Sep 2008.
    • 21 Sep 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top